The incidence of venous thromboembolism (VTE) in cancer patients is overall increased by 4 to 6.5 fold compared to the general population and affects up to 20% of patients with cancer, and represents a leading cause of death in this population [
]. However, individual VTE risk in cancer subjects widely varies depending on the specific patient-, treatment-, and cancer-related factors [
- Chew H.K.
- Wun T.
- Harvey D.
- Zhou H.
- White R.H.
Incidence of venous thromboembolism and its effect on survival among patients with common cancers.
Arch Intern Med. 2006; 166: 458-464
- Mandala M.
- Clerici M.
- Corradino I.
- et al.
Incidence, risk factors and clinical implications of venous thromboembolism in cancer patients treated within the context of phase I studies: the ‘SENDO experience’.
Ann Oncol. 2012; 23: 1416-1421
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to International Journal of Cardiology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Incidence of venous thromboembolism and its effect on survival among patients with common cancers.Arch Intern Med. 2006; 166: 458-464
- Incidence, risk factors and clinical implications of venous thromboembolism in cancer patients treated within the context of phase I studies: the ‘SENDO experience’.Ann Oncol. 2012; 23: 1416-1421
- Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action.J Clin Oncol. 2009; 27: 4919-4926
- Development and validation of a predictive model for chemotherapy-associated thrombosis.Blood. 2008; 111: 4902-4907
- High incidence of thromboembolic events in patients treated with cisplatin-based chemotherapy: a large retrospective analysis.J Clin Oncol. 2011; 29: 3466-3473
- Prediction of venous thromboembolism in cancer patients.Blood. 2010; 116: 5377-5382
- High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS).Blood. 2008; 112: 2703-2708
Published online: April 03, 2014
Accepted: March 14, 2014
Received: January 29, 2014
© 2014 Elsevier Ireland Ltd. Published by Elsevier Inc. All rights reserved.